Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blüthgen, Nils (1) Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (5) Kammertöns, Thomas Dr. (1) Leisegang, Matthias Dr. (5) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Selbach, Matthias Prof. Dr. (5) Uckert, Wolfgang Prof. Dr. (11) (-) Blankenstein, Thomas Prof. Dr. (2) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (8) (-) Molekulare Zellbiologie und Gentherapie (6) Signaltransduktion in Tumorzellen (1) 1998 (2) 2000 (2) 2001 (1) 2002 (2) 2003 (5) 2004 (1) 2005 (3) (-) 2006 (4) 2007 (1) 2008 (2) (-) 2010 (3) 2011 (2) 2013 (2) 2014 (4) 2015 (4) 2016 (2) 2017 (3) 2018 (1) 2019 (1) 7 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher 01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert 15. April 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Mai 2010 in Nat Med Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy G.M. Bendle C. Linnemann A.I. Hooijkaas L. Bies M.A. de Witte A. Jorritsma A.D.M. Kaiser N. Pouw R. Debets E. Kieback W. Uckert J.Y. Song J.B.A.G. Haanen T.N.M. Schumacher
01. Mai 2010 in Expert Opin Biol Ther Enhanced T cell receptor gene therapy for cancer E. Kieback W. Uckert
15. April 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken